Actively Recruiting
Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR）
Led by First Affiliated Hospital Xi'an Jiaotong University · Updated on 2024-07-12
2000
Participants Needed
1
Research Sites
242 weeks
Total Duration
On this page
Sponsors
F
First Affiliated Hospital Xi'an Jiaotong University
Lead Sponsor
5
521 Hospital of NORINCO Group
Collaborating Sponsor
AI-Summary
What this Trial Is About
In this study, by establishing a clinical cohort of infective endocarditis, we observed the natural prognosis and influencing factors in the process of disease development and regression; we used multi-omics technology to understand the prognostic value of its biomarkers, and provided new ideas and evidence for the pathogenesis, clinical diagnosis and treatment of IE.
CONDITIONS
Official Title
Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR）
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with clinically confirmed infective endocarditis
You will not qualify if you...
- Patients who refuse to sign informed consent form
- Patients with serious systemic diseases who cannot tolerate biological sample collection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Xian Jiantong University
Xi'an, Shaanxi, China, 710061
Actively Recruiting
Research Team
G
Guoliang Li
CONTACT
Y
Yang Yan
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here